Cipla shall now have exclusive rights for the development and commercialisation of Pulmazole in all countries except the United States of America
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Everest and SPH Kyuan will work closely to promote import and channel distribution of XERAVA in China
Resomer used in commercial 3D-printed implants for both soft and hard tissue applications
Advanz Pharma will leverage its specialty, hospital, and rare disease expertise and infrastructure to commercialize AT-007 in Europe for both Galactosemia and SORD Deficiency
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Orion to receive an upfront payment of USD 290 million
Under the terms of the agreement, Biogen will make an upfront payment of US $ 8 million to Xbrane
This certification validates the plant’s robust capabilities in manufacturing a wide range of sterile dosage forms
Subscribe To Our Newsletter & Stay Updated
